MOXIFLOXACINE EG 400 mg, film-coated tablet 5 tablets
Active ingredients: Moxifloxacin hydrochloride, Moxifloxacin
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet5 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- MOXIFLOXACINE EG 400 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVDC PVC aluminium de 5 comprimé(s)
- Marketing authorisation holder
- EG LABO - LABORATOIRES EUROGENERICS
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Jul 2014
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62422510CIP72735651CIP133400927356513Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MOXIFLOXACINEcomprimé | 400 mg · un comprimé | FT |
| CHLORHYDRATE DE MOXIFLOXACINEcomprimé | 436,8 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.